Tag: Brook Jackson
The regulators have not revoked approval of Pfizer's vaccine, which was approved by the FDA in late 2020, even after Brook Jackson disclosed problems at sites managed by Ventavia Research Group. Now, Pfizer is asking to dismiss the lawsuit revealing problems at COVID-19 vaccine trial sites entirely.
The company's recurrent inability to adequately operate facilities for Pfizer's COVID-19 vaccination study has been clearly documented. This has led to emergence of COVID vaccine trial whistleblower Brook Jackson filing a lawsuit against Pfizer for false claims.
